High Expression of FcγRIIb in Rheumatoid Arthritis
Author Information
Author(s): Magnusson Sofia E, Engström Marianne, Jacob Uwe, Ulfgren Ann-Kristin, Kleinau Sandra
Primary Institution: Uppsala University
Hypothesis
The study investigates the role of the inhibitory FcγRIIb in regulating synovial inflammation in rheumatoid arthritis (RA).
Conclusion
The study found that FcγRIIb is significantly expressed in RA synovium, suggesting its role in counteracting the effects of activating FcγRs.
Supporting Evidence
- FcγRIIb was abundantly expressed in RA synovia compared to healthy synovia.
- All activating FcγRs were significantly up-regulated in RA regardless of disease duration.
- Glucocorticoid treatment reduced FcγR expression in arthritic joints.
Takeaway
In rheumatoid arthritis, a special protein called FcγRIIb is found in high amounts in the joints, which helps control inflammation.
Methodology
The study analyzed synovial tissue from RA patients and healthy volunteers using immunohistochemistry to assess FcγR expression.
Participant Demographics
26 RA patients (12 men, 14 women) and 10 healthy volunteers (4 men, 6 women).
Statistical Information
P-Value
0.0104
Statistical Significance
p = 0.0104
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website